Chronic pain is best managed with a combination of nonpharmacologic strategies and selective non-opioid pharmacologic options tailored to the underlying condition, comorbidities, and patient preferences. The goal is improved function, reduced suffering, and lower risk of harm from long-term opioid use. Effectiveness varies by pain type, duration, and access to care.
Evidence from guidelines and trials
A clinical practice guideline authored by A. Qaseem, American College of Physicians emphasizes starting with nonpharmacologic therapies for many forms of chronic low back pain and other common chronic pain conditions before using medications. A randomized trial led by Daniel C. Cherkin, Group Health Research Institute compared mindfulness-based stress reduction, cognitive behavioral therapy, and usual care, finding both structured behavioral programs produced meaningful improvements in function and pain over usual care. These high-quality sources illustrate that structured psychological and physical interventions are evidence-based cornerstones of management.
Key effective treatments and how they work
Exercise therapy and supervised physical rehabilitation reduce pain by improving strength, flexibility, and pain modulation at the neural level while restoring daily function. Cognitive behavioral therapy targets pain-related thoughts and behaviors, helping patients regain activity despite pain and lowering disability. Mindfulness-based stress reduction and multidisciplinary rehabilitation combine physical, psychological, and educational components to change pain perception and coping, often producing durable benefit beyond short-term symptom relief. Response depends on engagement and program quality.
Among medications, nonsteroidal anti-inflammatory drugs provide useful symptomatic relief for many musculoskeletal conditions but carry gastrointestinal and cardiovascular risks with long-term use. Serotonin-norepinephrine reuptake inhibitors such as duloxetine have consistent evidence for chronic musculoskeletal and neuropathic pain and are recommended as alternatives to opioids when medication is appropriate. Topical agents and targeted anticonvulsants can help selected localized or neuropathic pain syndromes but show variable effectiveness across conditions.
Relevance, causes, and consequences include the cultural and territorial context: communities with limited access to physical therapists or behavioral pain programs may rely more on medications, increasing risk of harm. Social stigma around chronic pain and opioid use can shape treatment choices and adherence. Environmental factors such as occupation and built environment affect activity levels and recovery.
Shared decision making informed by guideline-based evidence, functional goals, and local resource availability is essential. Combining physical reconditioning, psychological therapies, and selective non-opioid medications offers the most effective, evidence-aligned pathway for long-term management of chronic pain.